Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLB | P06746 | 2/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.45 |
| ▸ | UBE2N | P61088 | 1/20 | 0.45 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.43 |
| ▸ | LMNA | P02545 | 1/20 | 0.43 |
| ▸ | LIPE | Q05469 | 1/20 | 0.43 |
| ▸ | SIRT2 | Q8IXJ6 | 1/20 | 0.42 |
| ▸ | C5AR1 | P21730 | 1/20 | 0.42 |
| ▸ | SLC2A1 | P11166 | 1/20 | 0.42 |
| ▸ | F2 | P00734 | 2/20 | 0.41 |
| ▸ | F10 | P00742 | 2/20 | 0.41 |
| ▸ | PRSS1 | P07477 | 2/20 | 0.41 |
| ▸ | PRSS2 | P07478 | 2/20 | 0.41 |
| ▸ | F7 | P08709 | 2/20 | 0.41 |
| ▸ | F3 | P13726 | 2/20 | 0.41 |
| ▸ | PRSS3 | P35030 | 2/20 | 0.41 |
| ▸ | RAB9A | P51151 | 3/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.41 |
| ▸ | NPC1 | O15118 | 2/20 | 0.41 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21462514 | 0.83 | POLB (0.45) | POLBKMT2AUBE2NKDM4ELMNA | |
| SCHEMBL30280437 | 0.80 | HPGD (0.49) | POLBKMT2AUBE2NKDM4ELMNA | |
| SCHEMBL8886562 | 0.80 | HPGD (0.49) | POLBKMT2AUBE2NKDM4ELMNA | |
| SCHEMBL9796196 | 0.79 | KMT2A (0.56) | KMT2AKDM4ELMNASMN1; SMN2MEN1 | |
| SCHEMBL19491100 | 0.79 | MEN1 (0.45) | KMT2AKDM4ESMN1; SMN2MEN1GAA | |
| SCHEMBL19490992 | 0.79 | MEN1 (0.45) | KMT2AKDM4ESMN1; SMN2MEN1GAA | |
| SCHEMBL17135848 | 0.79 | MEN1 (0.45) | KMT2AKDM4ESMN1; SMN2MEN1GAA | |
| SCHEMBL28900111 | 0.78 | KDM4E (0.45) | POLBKMT2AUBE2NKDM4ELMNA | |
| SCHEMBL9162464 | 0.78 | POLB (0.41) | POLBKMT2AUBE2NKDM4ELMNA | |
| SCHEMBL9360982 | 0.78 | F2 (0.49) | POLBKMT2AKDM4ELMNAF2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4698522-A1 | METHODS FOR PREPARING (-)-EPICATECHIN | Mars, Incorporated (US) | 2026-02-25 | — | — | EP | disclosed |
| US-20260042741-A1 | METHODS FOR PREPARING (-)-EPICATECHIN | MARS, INCORPORATED (US) | 2026-02-12 | — | — | US | disclosed |
| WO-2024220193-A1 | METHODS FOR PREPARING (-)-EPICATECHIN | MARS, INCORPORATED (US) | 2024-10-24 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260042741-A1 | METHODS FOR PREPARING (-)-EPICATECHIN | CYP2E1, CYP1A1, ADH1A | POLB 845/4885KMT2A 832/4885UBE2N 1388/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.